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Abstract
Neurogenesis in the adult brain is largely restricted to the subependymal zone (SVZ) of the lateral ventricle, olfactory bulb
(OB) and the dentate subgranular zone, and survival of adult-born cells in the OB is influenced by factors including sensory
experience. We examined, in mice, whether survival of adult-born cells is also regulated by the rate of precursor proliferation
in the SVZ. Precursor proliferation was decreased by depleting the SVZ of dopamine after lesioning dopamine neurons in
the substantia nigra compacta with 6-hydroxydopamine. Subsequently, we examined the effect of reduced SVZ
proliferation on the generation, migration and survival of neuroblasts and mature adult-born cells in the SVZ, rostral
migratory stream (RMS) and OB. Proliferating cells in the SVZ, measured by 5-bromo-2-deoxyuridine (BrdU) injected 2 hours
prior to death or by immunoreactivity against Ki67, were reduced by 47% or 36%, respectively, 7 days after dopamine
depletion, and by 29% or 31% 42 days after dopamine depletion, compared to sham-treated animals. Neuroblast generation
in the SVZ and their migration along the RMS were not affected, neither 7 nor 42 days after the 6-hydroxydopamine
injection, since the number of doublecortin-immunoreactive neuroblasts in the SVZ and RMS, as well as the number of
neuronal nuclei-immunoreactive cells in the OB, were stable compared to control. However, survival analysis 15 days after 6-
hydroxydopamine and 6 days after BrdU injections showed that the number of BrdU+ cells in the SVZ was 70% higher. Also,
42 days after 6-hydroxydopamine and 30 days after BrdU injections, we found an 82% increase in co-labeled BrdU+/c-
aminobutyric acid-immunoreactive cell bodies in the granular cell layer, while double-labeled BrdU+/tyrosine hydroxylase-
immunoreactive cell bodies in the glomerular layer increased by 148%. We conclude that the number of OB interneurons
following reduced SVZ proliferation is maintained through an increased survival of adult-born precursor cells, neuroblasts
and interneurons.
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Introduction
The mammalian nervous system arises from coordinated
proliferation, differentiation and migration of precursor cells
during embryonic and early postnatal development [1]. Although
most of these processes are completed by the perinatal period,
neurogenesis continues throughout adulthood in the subventricu-
lar or subependymal zone (SVZ) of the lateral ventricle and
olfactory bulb (OB) [2,3], as well as the subgranular zone of the
hippocampal dentate gyrus [4,5].
Adult olfactory precursors divide primarily within the SVZ,
where they differentiate into immature neurons. Neuroblasts then
migrate tangentially along the rostral migratory stream (RMS)
toward the main OB. When neuroblasts reach the OB, they
migrate radially into the granular (GCL), periglomerular (GL) and
external plexiform cell layers of the OB, and differentiate into local
interneurons [3,6,7,8] (Fig. 1).
Over recent decades, a wide range of molecular cues have been
identified to regulate neurogenesis during development, many of
which continue to influence neurogenesis in the adult [9,10,11,12].
The neurotransmitter dopamine (DA), for example, modulates the
cell cycle of lateral ganglionic eminence progenitors during
development through DA D1- and D2-like receptors [13]. In the
adult brain, dopaminergic (DAergic) fibers innervate the SVZ and
provide afferents to transit amplifying cells that express D1- and
D2-like receptors [14,15]. Proliferation of these and stem cells in
the adult SVZ is under the influence of D2-like receptors
[14,16,17], and depletion of DA innervation to the SVZ reduces
the number of proliferating cells in the SVZ [14,15,18,19]. More
recent studies have identified that DA-induced proliferation of
transit amplifying cells in the adult SVZ is mediated through
epidermal growth factor (EGF) and EGF receptor stimulation
[20], and ciliary neurotrophic factor [21].
Among the molecules governing migration of neuroblasts
through the RMS are members of the ephrin-B family [22], glial
cell line-derived neurotrophic factor [23,24], the polysialylated
form of the neural-cell adhesion molecule [25,26] and double-
cortin (DCX). DCX, a neuron specific microtubule associated
protein, is expressed on the cell body and leading processes of most
migrating postmitotic neuroblasts, and directs migration by
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up the cytoskeleton of neuroblasts [27,28,29]. DCX is expressed
by dividing neuroblast cells in the SVZ, and newly generated
neuroblasts continue to express DCX as they migrate through the
RMS and enter the OB [30]. Downregulation of DCX begins 10–
14 days after the birth of a neuroblast, and coincides with the
commencement of neuronal nuclei (NeuN) expression, as the cells
mature to become OB interneurons [30].
In the young adult, approximately 50% of adult-born cells that
migrate into the OB differentiate to form interneurons that
integrate into OB circuitry, while the other half undergo
programmed cell death as progenitors, neuroblasts or young
neuronal cells in the SVZ, RMS or OB [31,32,33]. At the
molecular level, noradrenergic [34,35] and cholinergic transmis-
sion [36,37,38], as well as cAMP response element binding protein
(CREB) signaling, are thought to play important roles in regulating
survival and death of adult-born cells residing in the OB.
Disruption of CREB signaling reduces the survival of newborn
neurons in the OB [39] and inhibits expression of the neurogenic
transcription factor Pax 6 [40]. Pax 6 regulates the survival of
mature OB DA neurons by controlling their expression of
crystalline aA, which prevents apoptosis by inhibition of
procaspase-3 activation [41]. At a more integrated level, survival
of adult-born OB cells is associated with sensory experience [42].
Enriched odor exposure [43] and learning of olfactory discrim-
ination [44] and associative [45] tasks are among the factors that
promote survival, and this depends on the age of the cell and its
location in the OB [46]. Sensory deprivation, on the other hand,
decreases survival of new granule cells [47,48].
While there is increasing understanding of specific factors that
control proliferation, migration and survival of adult-born cells in
the OB, it still remains unclear whether the rate of neuronal
precursor generation in the SVZ influences the longevity of
differentiated precursors integrated in the OB. The proliferative
rate of precursors in the SVZ and survival of cells in the OB
appears linked because the volume of the OB does not
substantially change throughout life [32,49,50,51]. To establish
if this is the case, we experimentally reduced the number of
proliferating precursor cells in the mouse SVZ, and analyzed
neuroblast formation in the SVZ, neuroblast migration through
the RMS, as well as the phenotype and survival of OB
interneurons.
Results
The effect of reduced cell proliferation in the SVZ of the adult
mouse on the generation of neuroblasts in the SVZ, their
migration through the RMS, and their survival in the OB was
examined. The rate of precursor cell proliferation in the SVZ was
lowered by reducing DA innervation to the striatum and SVZ
[14]. This was achieved by injecting 6-hydroxydopamine-hydro-
bromide (6-OHDA) into the substantia nigra pars compacta (SNc)
to destroy local DA-producing neurons and their nigrostriatal
projections. We then performed stereological quantification to
examine whether reduced SVZ proliferation altered: 1) the
number of neuroblasts generated in the SVZ and RMS; 2) the
number of neuroblasts migrating through the RMS; 3) the number
of interneurons present in the OB; and 4) the survival of newborn
cells in the OB. Results from individual experiments are presented
first, followed by a summary of results in Table 1.
6-OHDA injections into the SNc decreases striatal/SVZ DA
innervation
Reduced striatal/SVZ DA innervation following 6-OHDA
administration to the SNc was confirmed by immunohistochem-
istry for tyrosine hydroxylase (TH), performed on striatal sections
of lesioned animals. 7 or 42 days after 6-OHDA administration
there were only occasional TH-immunoreactive (ir) fibers present
in the SVZ of lesioned animals (Fig. S1).
Reduced DA innervation lowers the number of
proliferating cells in the SVZ
To examine the effect of reduced striatal/SVZ DA innervation
on cell proliferation in the SVZ and RMS, 5-bromo-2-deoxyur-
idine (BrdU) (150 mg/kg i.p.) was injected in mice 2 hours prior to
death to label cells in S-phase of the cell cycle (see Fig. 2A). 7 days
Figure 1. Neurogenesis in the adult rodent SVZ and OB. Schematic sagittal view of the adult mouse brain. 1) Adult-born olfactory precursors
(stem cells/transit amplifying cells) proliferate primarily within the SVZ where they 2) differentiate into immature neurons (neuroblasts). 3)
Neuroblasts then migrate tangentially along the RMS toward the main OB, which requires 2–6 days. Arrow indicates the direction of neuroblast
migration through the RMS. 4) On days 5–7 after birth, adult-born neuroblasts migrate radially towards the granular, periglomerular and external
plexiform cell layers of the OB. 5) 15–30 days after birth, adult-born cells in the OB mature to form local interneurons that display extensive dendritic
arborizations (see [9,10,32]). GCL, granular cell layer; GL, glomerular layer; RMS, rostral migratory stream; SVZ, subependymal zone.
doi:10.1371/journal.pone.0031549.g001
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(BrdU+) cell bodies in the SVZ was 47% lower than the number in
control mice injected with 0.9% sodium chloride (NaCl) (Fig. 3A,
E, F), while in the RMS, the 25% decrease in BrdU+ cells was not
statistically different from control (Fig. 3B). 42 days after lesioning,
the number of BrdU+ cell bodies in the SVZ were down 29%
(Fig. 3A, E, G), while in the RMS, the 17% increase in BrdU+ cells
was not statistically different from control (Fig. 3B). There was a
37% increase in BrdU+ proliferating cells between 7 and 42 days
after 6-OHDA injections were performed (Fig. 3A, B), suggesting a
partial recovery in cell proliferation over time following disruption
of striatal/SVZ DA innervation.
Immunoreactivity against Ki67 labels cells in all phases of
mitosis, except G1, and was used to identify dividing cells in the
SVZ and RMS. In the SVZ, Ki67-ir cell bodies were down 36%
and 31% 7 and 42 days, respectively, after 6-OHDA was injected
into the SNc (Fig. 3C, H–J), while in the RMS the 33% and 51%
reduction in Ki67-ir cells, respectively, was not statistically
different from control (Fig. 3D).
AlthoughproliferatingcellsintheSVZandRMSwerereducedby
a similar proportion, there were far more dividing cells in the SVZ,
so in absolute numbers, the greatest reduction in BrdU+ and Ki67-ir
proliferating cells occurred in the SVZ (Fig. 3A cf. 3B, 3C cf. 3D).
Reduced precursor proliferation in the SVZ has no effect
on the number of mature neurons in the OB
As cells born in the SVZ migrate along the RMS toward the
OB, where they differentiate into local interneurons [3,6,7,8], we
examined the effect that reduced proliferation in the SVZ had on
the number of mature interneurons in the OB. Mature OB
interneurons were identified using an antibody against NeuN.
Despite the reduction in precursor proliferation in the SVZ, the
number of NeuN-ir cell bodies in the GCL and GL of the OB
were unchanged 7 or 42 days after injection of 6-OHDA into the
SNc (Fig. 3K, L).
Reduced SVZ cell proliferation has no overall effect on
the number of DCX-ir neuroblasts in the SVZ and RMS
Because reduced cell proliferation in the SVZ did not alter the
total number of mature OB neurons, we next examined whether
the number of neuroblasts in the SVZ and RMS were altered.
Neuroblasts in these regions were identified by immunoreactivity
against DCX [27,28,30]. We found that the number of DCX-ir
neuroblasts in the SVZ and RMS 7 and 42 days after 6-OHDA
was injected into the SNc was similar to control animals (Fig. 4A,
B, N–P).
Table 1. Summary of results, demonstrating the change in the number of cell bodies in the SVZ, RMS, GCL and GL of 6-OHDA
injected animals when compared to control.
Subventricular Zone
Protocol BrdU Ki67 DCX




Protocol BrdU Ki67 DCX




Protocol BrdU BrdU/GABA GABA CalR NeuN
1 /= (6A) /= (6D) =/= (3K)
2
3 q (5A) q (5D)
Glomerular Layer
Protocol BrdU BrdU/TH GABA TH GABA/TH CalR CalB NeuN
1 =/= (6G) q/q (6H) q/q (6I) =/Q (6M) =/= (6N) =/= (3L)
2
3 q (5H) q (5L)
Protocol 1. A single dose of BrdU (150 mg/kg i.p.) was administered 2 hours prior to death, 7 or 42 days after the 6-OHDA or NaCl injections (n=4 for each experimental
group) (see Fig. 2A). First symbol represents 7 day group; second symbol corresponds to 42 day group. Protocol 2. BrdU (50 mg/kg, i.p.) was administered twice daily for
3 consecutive days beginning 7 days after 6-OHDA (n=4) or NaCl (n=4) injections into the SNc, and mice killed 6 days later (i.e. 15 days after 6-OHDA administration)
(see Fig. 2B). Protocol 3. BrdU (50 mg/kg, i.p.) was administered twice daily for 5 consecutive days, beginning 8 days after 6-OHDA (n=4) or NaCl (n=4) was injected into
the SNc, and mice killed 30 days later (i.e. 42 days after 6-OHDA administration) (see Fig. 2C). Q corresponds to reduced number of cell bodies in comparison to control;
q corresponds to increased number of cell bodies; =corresponds to no statistical change in number of cell bodies. Numbers and letters in brackets refer to
corresponding figure.
doi:10.1371/journal.pone.0031549.t001
Reduced Proliferation Influences Neuron Survival
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31549Impact of reduced SVZ proliferation on migration of
neuroblasts through the RMS
The effect of reduced precursor proliferation in the SVZ on the
migration of neuroblasts through the RMS was examined by
administering BrdU (50 mg/kg i.p.) twice daily for 3 consecutive
days, beginning 7 days after 6-OHDA (or sham) injections. The
mice were killed 6 days after the last BrdU administration to allow
quantification of the distance that neuroblasts had migrated
through the RMS [33] (see Fig. 2B).
6 days after the last BrdU administration (i.e. 15 days after 6-
OHDA administration), the number of BrdU+ cell bodies in the
SVZ increased by 70% in lesioned mice (Fig. 4C), while in the
RMS, where most BrdU+ cells were located, the 3% increase in
lesioned mice was not statistically different from control
(Fig. 4D).
When the number of BrdU+ cell bodies was plotted against
distance rostral to the convergence of the anterior commissure
(Fig. 4E), it was apparent that the number of BrdU+ cell
bodies along the RMS (i.e. 1700–4000 mm rostral to the
anterior commissure) was similar in control mice and mice
administered with 6-OHDA (Fig. 4E, H, I). Thus, the rate of
migration through the RMS, measured by the distance travelled
by BrdU+ cells from the SVZ, was similar in mice with
reduced proliferation in the SVZ and controls. In contrast, 6
days after the last BrdU administration, there were consistently
greater numbers of BrdU+ cell bodies throughout the SVZ
of 6-OHDA injected mice (i.e. 0–1100 mm rostral to the
anterior commissure) than in control animals, the increase
ranging from 39–106% at the 3 points examined in the SVZ
(Fig. 4E–G).
Figure 2. Experimental design. At the beginning of each experiment (Day 0), mice received injections of either 6-OHDA or 0.9% NaCl (control)
into the SNc. (A) Protocol 1. To identify proliferating cells in the SVZ and RMS, a single dose of BrdU (150 mg/kg i.p.) was administered 2 hours prior to
death, 7 or 42 days after the 6-OHDA or NaCl injections (n=4 for each experimental group). From these animals, the number of BrdU+ (Fig. 3A, B, E–
G), Ki67-ir (Fig. 3C, D, H–J) and DCX-ir (Fig. 4A, B, N–P) cell bodies in the SVZ and RMS were estimated, as were the number of GFAP-ir glial cells in the
SVZ (Fig. 4Q, R), and the number of NeuN-ir (Fig. 3K, L), GABA-ir (Fig. 6A–C, G–L), calretinin-ir (Fig. 6D–F, M, O, P), TH-ir (Fig. 6H–J) and calbindin-ir
(Fig. 6N, Q–R) cell bodies in the OB. (B) Protocol 2. To identify migrating neuroblasts in the RMS and the extent of their migration along the RMS, BrdU
(50 mg/kg, i.p.) was administered twice daily for 3 consecutive days beginning 7 days after 6-OHDA (n=4) or NaCl (n=4) injections into the SNc, and
mice were killed 6 days later (i.e. 15 days after 6-OHDA administration). From these animals, the number of BrdU+ and DCX-ir cell bodies in the SVZ
and RMS were quantified (Fig. 4C–M, S, T). (C) Protocol 3. To label mature adult-born cells that migrate to, integrate and survive in the GCL and GL,
BrdU (50 mg/kg, i.p.) was administered twice daily for 5 consecutive days, beginning 8 days after 6-OHDA (n=4) or NaCl (n=4) was injected into the
SNc, and mice killed 30 days later (i.e. 42 days after 6-OHDA administration). From these animals, the number of BrdU+ cell bodies in the GCL (Fig. 5A–
G) and GL (Fig. 5H–M) were estimated, as were the number of BrdU/GABA co-expressing cells in the GCL (Fig. 5D–G), and the number of BrdU/TH co-
expressing cells in the GL (Fig. 5K–M).
doi:10.1371/journal.pone.0031549.g002
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corresponds with a higher number of DCX-ir neuroblasts
Double-immunofluorescence histochemistry for BrdU and
DCX was performed to reveal the identity of the BrdU+ cell
bodies in the SVZ. 6 days after the last administration of BrdU to
control mice or those that received 6-OHDA injections, most
BrdU+ cell bodies in the SVZ co-expressed DCX-like immuno-
reactivity (LI) (Fig. 4J, K, S, T). Together with the 70% increase in
the number of BrdU+ cell bodies observed in the SVZ of 6-OHDA
injected mice (Fig. 4C), our data suggest that BrdU+ cells in the
SVZ 6 days after BrdU administration were DCX-ir neuroblasts.
Impact of reduced striatal/SVZ DA innervation on GFAP-ir
astrocytes in the SVZ
We also performed immunohistochemistry for glial
fibrillary acidic protein (GFAP,F i g .4 R )t od e t e r m i n ew h e t h e r
reduced cell proliferation i nt h eS V Zh a da ne f f e c to nt h e
number of astrocytes [52]. There were 42% more GFAP-ir
astrocytes in the SVZ 7 days after 6-OHDA administration
compared to control mice (Fig.4 Q ) .4 2d a y sa f t e r6 - O H D A
was injected into the SNc, the 5% increase of GFAP-ir
astrocytes in the SVZ was not significantly different from
control (Fig. 4Q).
Figure 3. Proliferation in the SVZ and RMS following 6-OHDA injections into the SNc. BrdU was administered 2 hours before animals were
killed (see Protocol 1, Fig. 2A), and BrdU+ cells in the SVZ and RMS were quantified. (A–D) Estimated number of BrdU+ (A) and Ki67-ir (C) cell bodies in
the SVZ. Estimated number of BrdU+ (B) and Ki67-ir (D) cell bodies in the RMS. (E–G) Photomicrographs of BrdU-LI in the SVZ of control mice (E), and
mice 7 (F) or 42 days (G) after 6-OHDA was administered to deplete striatal DA. (H–J) Photomicrographs of Ki67-LI in the SVZ of control mice (H), and
mice 7 (I) or 42 days (J) after striatal DA denervation. (K, L) Estimated number of NeuN-ir cell bodies in the GCL (K) and GL (L) of control mice, and mice
7 or 42 days after 6-OHDA administration. In plots (A–D) and (K), (L), white bars=control animals (n=4), grey bars=mice 7 days after 6-OHDA
injection (n=4), and black bars=42 days after 6-OHDA administration (n=4). Control animals received injections of 0.9% NaCl into the SNc. CC,
corpus callosum; LV, lateral ventricle; St, striatum; SVZ, subventricular zone; 7D, 7 days post 6-OHDA injection; 42D, 42 days post 6-OHDA injection.
Scale bar in G=50 mm, applies E–J. * corresponds to P,0.05.
doi:10.1371/journal.pone.0031549.g003
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31549Figure 4. Effect of reduced proliferation in the SVZ on the generation of neuroblasts and their migration through the RMS. (A, B)
Estimated number of DCX-ir neuroblasts in the SVZ (A) or RMS (B) of control mice (white bars), and mice 7 (grey bars) or 42 days (black bars) after 6-
OHDA injections were performed to lesion the SNc (see Protocol 1, Fig. 2A). (C–M, S, T) BrdU (50 mg/kg i.p.) was administered twice daily for 3
consecutive days, beginning 7 days after 6-OHDA or sham injections, and mice were killed 6 days after the last BrdU administration (see Protocol 2,
Fig. 2B). (C, D) Estimated number of BrdU+ cell bodies in the SVZ (C) or RMS (D) of control mice (white bars), and mice 15 days after 6-OHDA was
injected (black bars). (E) Estimated number of BrdU+ cell bodies in the RMS of control or 6-OHDA injected mice, plotted according to distance rostral
to the AC. Note the increase in BrdU+ cells in the SVZ of 6-OHDA injected animals. Photomicrographs showing BrdU-LI in the SVZ (F, G) and RMS (H, I)
of control and 6-OHDA injected mice. Double-immunofluorescence confocal micrographs of BrdU- (red) and DCX-LI (green) in the SVZ (J, K) and RMS
(L, M) of control (J, L) and 6-OHDA injected (K, M) mice. (S, T) Double-immunofluorescence confocal micrographs of BrdU- (red) and DCX-LI (green) in
the SVZ of control (S) and 6-OHDA injected (T) mice, shown at higher magnification. Note increased number of double-labeled cells in the SVZ of 6-
OHDA injected mice. (N–P) Photomicrographs of DCX-ir neuroblasts in the RMS of control mice (N), and 7 (O) or 42 days (P) after 6-OHDA injection
into the SNc (see Protocol 1, Fig. 2A). (Q, R) Estimated number of GFAP-ir astrocytes in the SVZ of control mice (white bar), and 7 (grey bar) or 42 days
(black bar) after 6-OHDA administration (Q) (see Protocol 1, Fig. 2A). (R) Double-immunofluorescence confocal micrograph of GFAP-LI (green) and
Hoechst staining (blue) in the SVZ, the later providing a nuclear counter stain. In plots (A), (B) and (Q), white bars=control animals (n=4), grey
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precursor proliferation in the SVZ is reduced
We next examined the effect of reduced SVZ precursor
proliferation on the number of newborn cells that migrate to,
integrate and survive in the GCL and GL of the OB. BrdU
(50 mg/kg i.p.) was administered twice daily for 5 consecutive
days, beginning 8 days after 6-OHDA (or sham) injections. The
mice were killed 30 days after the last BrdU administration, a
suitable period for assessing the number of newly born cells that
have matured and survived in the OB [31,32,33] (see Fig. 2C). In
the GCL, the number of BrdU+ cell bodies observed in mice
administered with 6-OHDA was 42% greater than in control mice
(Fig. 5A–C).
Because interneurons in the GCL predominantly express c-
aminobutyric acid (GABA), double-immunofluorescence histo-
chemistry for GABA and BrdU was performed to examine
whether reduced SVZ proliferation led to a change in the number
of BrdU+ newborn cells that had differentiated into GABA-ir
interneurons. 30 days after the last BrdU administration, the
number of cells in the GCL that were BrdU+ and contained
GABA-LI was 82% greater in 6-OHDA-injected mice than in
control mice (Fig. 5D–F). Although the proportion of BrdU+ cell
bodies in the GCL that co-expressed GABA-LI increased from
36% in control mice to 45% in mice administered with 6-OHDA
(Fig. 5G), this change was not statistically different.
In the GL, the number of BrdU+ cell bodies observed in mice
following 6-OHDA administration was 143% greater than in
control mice (Fig. 5H–J). Double-immunofluorescence histochem-
istry for BrdU and TH was then performed (Fig. 5K) to determine
whether the increased number of BrdU+ cells in the GL was
associated with a rise in DAergic interneurons. We found that the
number of BrdU+ cells in the GL that co-labeled TH-LI increased
by 148% in mice administered with 6-OHDA when compared
with control (Fig. 5L). In the GL of control mice, 21% of BrdU+
cells co-expressed TH-LI, which was similar to the proportion of
BrdU+ cells co-expressing TH-LI in mice that received 6-OHDA
(Fig. 5M).
The effect of reduced precursor proliferation in the SVZ
on the subclasses of interneurons in the OB
Several subclasses of granular and periglomerular cells exist in
the OB, identified by expression of GABA, TH [53], calbindin and
calretinin [54,55,56]. We examined whether reduced proliferation
in the SVZ affected the number of interneurons in each of these
subclasses. In the GCL, the number of GABA-ir (Fig. 6A–C) or
calretinin-ir cell bodies (Fig. 6D–F) was similar in control mice,
and in mice 42 days after 6-OHDA administration.
In the GL, the number of GABA-ir cell bodies in mice 7 or 42
days after 6-OHDA administration was greater than, but not
statistically different from control (Fig. 6G, K, L). In contrast, the
21% and 20% increase in the number of TH-ir cell bodies in the
GL 7 and 42 days after 6-OHDA injection, respectively, was
statistically different from control mice (Fig. 6H, K, L). Double-
labeling experiments revealed that the number of cells co-
expressing GABA- and TH-LI increased 36% and 29% in mice
7 and 42 days after 6-OHDA injection, respectively (Fig. 6I, K, L).
Despite the increased number of double-labeled GABA/TH cell
bodies, the proportion of GABA-ir cells in the GL that co-
expressed TH-LI was similar in control mice and mice 7 and 42
days after 6-OHDA administration (Fig. 6J).
In the GL, the number of calretinin-ir cell bodies was similar to
control inmice7 daysafter6-OHDA injection.However,inmice42
days after 6-OHDA administration, 21% fewer calretinin-ir cell
bodies were observed (Fig. 6M, O, P). Finally, the number of
calbindin-ir cell bodies in the GL of mice 7 and 42 days following 6-
OHDA injection wasnot different from control mice (Fig. 6N, Q–S).
Discussion
We examined the influence of a reduced number of prolifer-
ating precursor cells in the adult SVZ on the generation of
neuroblasts, their migration through the RMS and their survival in
the OB. Proliferating precursor cells in the SVZ of adult mice were
reduced by injecting 6-OHDA to lesion DA cells in the SNc and
deplete DAergic afferents that innervate the striatum and SVZ
[14,19]. Our data indicate that reducing precursor proliferation in
the SVZ had no effect on the total number of mature neurons in
the OB because: 1) the number of NeuN-ir cell bodies in the GCL
and GL was similar to control 7 or 42 days after 6-OHDA was
injected into the SNc; 2) The number of migrating neuroblasts and
DCX-ir neuroblasts in the RMS and SVZ was not changed 7 or
42 days after 6-OHDA administration; and 3) the rate of
neuroblast migration through the RMS was similar to control in
mice with reduced proliferation in the SVZ. However, the
numbers of both BrdU+ neuroblasts in the SVZ and BrdU+
adult-born mature neurons in the OB 15 and 42 days after 6-
OHDA injection, respectively, were increased, suggesting that
newborn cells have the capacity to survive for a greater period
than normal when proliferation in the SVZ is reduced.
Previous studies demonstrated that striatal DA denervation
reduces the number of proliferating cells in the SVZ. Treating
mice with 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine (MPTP)
depleted striatal DA innervation and reduced the number of SVZ
cells expressing the cell cycle marker proliferating cell nuclear
antigen (PCNA) by ,45% and ,30% 1 and 7 days after
administration, respectively [14]. Similarly, 14 [19] and 42 days
[14] after administration of 6-OHDA into the rat nigrostriatal
pathway, depletion of striatal DA reduced the number of PCNA+
cells in the SVZ by ,35%. In this study we used the nuclear
protein Ki67, which labels cells in all phases of mitosis except G1
[57], to identify proliferating cells. In line with previous reports,
our results show a reduction in the number of Ki67-ir cell bodies
in the SVZ of 36% and 31%, respectively, 7 and 42 days after 6-
OHDA administration. Proliferating cells were also identified by
administering BrdU, which incorporates into DNA of dividing
cells during the S-phase of the cell cycle [58], to mice with striatal/
SVZ DA-depletion 2 hours prior to their death. We found 47%
fewer BrdU+ cell bodies in the SVZ 7 days after 6-OHDA
administration, and 29% less after 42 days. Thus, our experiments
have used a robust model of reduced SVZ proliferation.
Our results point to a regulation of neurogenesis in the olfactory
system, so that a steady neuronal population in the OB is
maintained. Despite a reduction in proliferating cells in the SVZ
caused by 6-OHDA, the number of neuroblasts in the SVZ and
RMS was unaltered, and tangential migration of neuroblasts in the
RMS was maintained [6]. In addition, 6 days after the last BrdU
pulse, the number of BrdU+ cell bodies in the SVZ was increased
bars=mice 7 days after 6-OHDA injection (n=4), and black bars=42 days after 6-OHDA administration (n=4). For control and lesion groups in plots
C–E, n=4. Control animals received injections of 0.9% NaCl into the SNc. Scale bars: I=50 um, applies F–I; J=20 um, applies J–M; P=100 um. applies
N–P; R=10 um; T=20 um, applies S, T. * corresponds to P,0.05.
doi:10.1371/journal.pone.0031549.g004
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two explanations for the latter observation: 1) the release of adult-
born neuroblasts from the SVZ into the RMS was delayed; and/or
2) cells generated in the SVZ and RMS after DA depletion
survived longer than normal. Arguing against a delayed release of
neuroblasts from the SVZ is the normal number of BrdU+ cell
bodies in the RMS 6 days after the last BrdU administration. In
support of the notion that adult-born cells survive for longer than
normal are our findings that despite a reduced number of
proliferating cells in the SVZ: 1) most BrdU+ cell bodies in the
SVZ were DCX-ir neuroblasts; 2) the rate of neuroblast migration
through the RMS was similar to control, with the number of
BrdU+ cell bodies throughout the RMS being unaltered 6 days
after the last BrdU pulse; and 3) the number of mature BrdU+
interneurons in the GL and GCL that expressed TH- and GABA-
LI was greater than control 30 days after the last BrdU pulse.
Figure 5. The number of adult-born cells in the OB increases when precursor proliferation in the SVZ is reduced. BrdU (50 mg/kg i.p.)
was administered twice daily for 5 consecutive days, beginning 8 days after 6-OHDA (or sham) injection, and mice killed 30 days after the last BrdU
administration (i.e., 42 days after 6-OHDA injection; see Protocol 3, Fig. 5C). (A–G) Estimated number of BrdU+ cell bodies in the GCL of control (white
bar) and 6-OHDA injected mice (black bar) (A). Photomicrograph of BrdU+ cell bodies in the GCL of control (B) and 6-OHDA injected (C) mice. (D)
Estimated number of BrdU+ and GABA-ir double-labeled cell bodies in the GCL of control (white bar) and 6-OHDA injected mice (black bar).
Photomicrograph of BrdU- (red) and GABA-LI (green) in the GCL of control (E) and 6-OHDA injected (F) mice. (G) Estimated number of BrdU+/GABA-ir
co-expressing cell bodies expressed as a proportion of the total number of BrdU+ cell bodies in the GCL of control (white bar) and 6-OHDA injected
mice (black bar). (H–M) Estimated number of BrdU+ cell bodies in the GL of control (white bar) and 6-OHDA injected mice (black bar) (H).
Photomicrograph of BrdU+ cell bodies in the GL and EPL of control (I) and 6-OHDA injected (J) mice. (K) Double-immunofluorescence confocal
micrographs of BrdU- (red) and TH-LI (green) in the GL of mouse with striatal/SVZ DA-depletion. (L) Estimated number of BrdU+ and TH-ir double
labeled cell bodies in the GL of control (white bar) and 6-OHDA injected mice (black bar). (M) Estimated number of BrdU+/TH-ir co-expressing cell
bodies expressed as a proportion of the total number of BrdU+ cell bodies in the GL of control (white bar) and 6-OHDA injected mice (black bar). In
plots (A), (D), (G), (H), (L), (M), white bars=control animals (n=4), and black bars=6-OHDA-injected animals (n=4). Control animals received
injections of 0.9% NaCl into the SNc. In (G), (L) and (M) coex=co-expressing. Scale bars: C=100 um, applies B, C; F=40 um, applies E, F; I=100 um,
applies I, J; K=10 um. * corresponds to P,0.05.
doi:10.1371/journal.pone.0031549.g005
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31549Figure 6. The effect of reduced precursor proliferation in the SVZ on subclasses of interneurons in the GCL and GL. The number of
interneurons in the GCL and GL were estimated in animals administered with BrdU 2 hours prior to death (see Protocol 1, Fig. 2A). (A–C) Estimated
number of GABA-ir cell bodies in the GCL of control mice (white bar), and mice 42 days after 6-OHDA injection (black bar) (A). Photomicrographs of
GABA-LI in the GCL of control mouse (B) and 42 days after 6-OHDA injection (C). (D–F) Estimated number of calretinin-ir cell bodies in the GCL of
control mice (white bar), and mice 42 days after 6-OHDA injection (black bar) (D). Photomicrographs of calretinin-LI in the GCL of control mouse (E)
and 42 days after 6-OHDA injection (F). Estimated number of GABA-ir (G) and TH-ir (H) cell bodies in the GL of control mice, and mice 7 or 42 days
following 6-OHDA injection. (I) Estimated number of GABA and TH double-labeled cell bodies in the GL of control mice, and mice 7 or 42 days after 6-
OHDA injection. (J) Estimated number of GABA-ir/TH-ir co-expressing cell bodies expressed as a proportion of the total number of GABA-ir cell bodies
in the GL of control mice, and mice 7 or 42 days after 6-OHDA injection. (K, L) Double-immunofluorescence photomicrographs of TH- (green) and
GABA-LI (red) in the GL of control mice (K), and mice 42 days after 6-OHDA injection (L). Estimated number of calretinin-ir (M) and calbindin-ir (N) cell
bodies in the GL of control mice, and mice 7 or 42 days after 6-OHDA injection. (O, P) Photomicrographs of calretinin-LI in the GL of control mice (O),
and mice 42 days after 6-OHDA injection (P). (Q–S) Photomicrographs of calbindin-LI in the GL of control mice (Q), and mice 7 (R) or 42 (S) days after
6-OHDA injection. In plots (A) and (D), white bars=control animals (n=4), and black bars=6-OHDA-injected animals (n=4). In plots (G–J), (M), and
(N), white bars=control animals (n=4), grey bars=mice 7 days after 6-OHDA injection (n=4), and black bars=42 days after 6-OHDA injection (n=4).
Control animals received injections of 0.9% NaCl into the SNc. In (J) coex=co-expressing. CalR=calretinin; CalB=calbindin. Scale bars: C=100 um,
applies B, C; F=50 um, applies E, F; L=50 um, applies K, L; P=50 um, applies O, P; Q=50 um, applies Q–S. * corresponds to P,0.05.
doi:10.1371/journal.pone.0031549.g006
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tions examined in the GL responded differently to reduced
proliferation in the SVZ. 42 days after striatal DA denervation, the
number of calbindin-ir cell bodies in the GL was not altered. This
suggests that reduced SVZ proliferation in the adult has a limited
influence on these cells, most of which are generated early in life
[56]. In contrast, calretinin- and TH-ir cell bodies are predom-
inantly generated in the adult [31,56,59] and their numbers were
affected, with fewer calretinin-ir cell bodies and more TH-ir cells
in the GL 42 days after striatal DA denervation. Such plasticity in
the population of TH- and calretinin-ir interneurons may reflect
their ability to adapt to continuously changing odor environments
[60].
A greater number of BrdU+ cell bodies that expressed GABA-
and/or TH-LI were observed in the OB of DA-depleted mice 42
days after 6-OHDA administration. Increased numbers of
BrdU+/TH-ir cell bodies in the periglomerular region of the
OB are consistent with previous observations [19], while to our
knowledge, this is the first report of increased BrdU+/GABA-ir
cell bodies in the GCL following striatal/SVZ DA depletion. The
longevity of adult-born cells therefore appears to have increased,
which should contribute to maintaining normal numbers of
mature neurons in the GCL and GL of the OB.
Our findings are in contrast to previous reports that used agents
that cause permanent and often complete suppression of
proliferation in the SVZ, and that examined the effects of reduced
SVZ proliferation over a much longer period. Imayoshi and
colleagues [61] found a gradual decrease in granule cells from 3–
12 weeks following the genetic ablation of newly formed neurons
in adult mice. Other recent studies of OB neurogenesis used the
antimitotic agent cytosine-b-D-arabinofuranoside (Ara-C) and x-
ray or gamma-ray irradiation to restrict proliferation in the SVZ
[62,63,64]. While we found that the number of neuroblasts in the
SVZ, RMS and OB was unchanged 7 or 42 days after striatal DA
depletion, DCX-ir neuroblasts were almost completely absent
following a 28 day infusion of Ara-C [62], or reduced by 70% 7
months following gamma-ray irradiation [65]. Accordingly, the
prolonged survival of neuroblasts and GABA and TH cell bodies
following partial suppression of proliferation in the SVZ may not
be able to maintain a normal number of cells in the OB long-term,
and this might become manifest over a longer period of time, by a
reduction in migrating neuroblasts in the RMS and mature OB
interneurons. This was the case when proliferating cells in adult
mice were genetically ablated [61].
The OB contained a normal number of mature OB
interneurons, but a greater proportion of mature, adult-born,
GABA- and TH-ir interneurons 42 days after striatal DA-
depletion. The escalated integration and survival of these adult-
born cells, together with changes in subtype of interneuron
present in the OB, may alter the complex circuitry that exists
within the OB. This includes the intricate arrangement of
dendrites in the external plexiform layer that are derived from
mitral, granule and tufted cells that engage in dendro-dendritic
reciprocal synaptic interactions with each other [66,67,68,
69,70,71,72], and the interactions of periglomerular cells in the
glomerular layer [73,74,75,76]. Because of the greater proportion
of adult-born interneurons making up OB circuitry, functional
properties of mitral and tufted cells (e.g. their odorant-evoked
firing properties [77]) and the timing of the transmission of
olfactory information and bulbar output may be altered. Thus, it
would be interesting to determine whether deficits in olfactory
functioning, e.g. short- and long-term odor memory, odor
discrimination and fear conditioning [43,62,65,78,79,80,81],
exist following striatal DA depletion, and whether such deficits
are restored in the face of extended survival of adult-born
neurons in the OB.
In conclusion, using a model of striatal DA depletion, we show
that a moderate reduction of proliferation in the SVZ does not
alter the number of mature neurons in the OB, owing to an
increased survival of neuroblasts in the SVZ and RMS, and adult-
born cells that matured into GABA- or TH-expressing interneu-
rons in the OB. Further investigations are needed to understand




Ethics Statement. All experimental procedures performed in
this study conformed to the Australian National Health and
Medical Research Council published code of practice, and were
approved by the Florey Neuroscience Institutes’ Animal Ethics
Committee (#09-053). 32 male 12-week old C57BL/6 mice
weighing between 25–30 g were used, and animals were
maintained under standard conditions on a 12 h day/night
cycle, with water and food ad libitum.
Lesioning of DA neurons in the substantia nigra pars
compacta
Anesthesia was induced in mice by inhalation of 5% isoflurane
(Delvet, Seven Hills, NSW, Australia). Mice were then transferred
onto a stereotaxic apparatus (Kopf Instruments, Tujunga, CA).
Subsequently, anesthesia was maintained with 1.5% isoflurane
through a nose cone at the level where a hind paw pinch reflex
could not be elicited. 6-OHDA, (Sigma-Aldrich, St. Louis, MO)
was used to destroy DAergic neurons in the SNc and their
terminals in the striatum and SVZ. 6-OHDA was prepared to a
concentration of 2 mg/ml in sterile 0.9% NaCl containing 0.02%
ascorbic acid, and was kept on ice until injected. 1.5 ml of the 6-
OHDA solution (or 1.5 ml of sterile 0.9% NaCl for control
animals) was infused into the right SNc using a glass micropipette
attached to a 5 ml Hamilton syringe. Injection coordinates were:
3.0 mm posterior to Bregma, 1.2 mm lateral to the midline and
4.3 mm ventral to the surface of the brain [82,83]. The injections
were delivered over a period of 2 min after which the micropipette
was left in position for a further 2 min before being removed at a
rate of 1 mm/min. Meloxicam (Troy Laboratories, Smithfield,
NSW, Australia, 3 mg/kg i.m.) was administered immediately post
surgery for analgesia.
BrdU administration
BrdU (ICN Biomedicals Inc, Aurora, Ohio, Cat No. 100171)
was administered intraperitoneally to 6-OHDA administered and
control mice to study the proliferation, migration and survival of
adult-born cells in the SVZ, RMS and OB. Three different
protocols were used to identify either proliferating cells in the
SVZ, migrating cells through the RMS, or mature cells in the OB
(Fig. 2): 1) To enable identification of proliferating cells in the SVZ
or RMS, a single dose of BrdU (150 mg/kg, i.p.) was injected
2 hours prior to death, 7 or 42 days after 6-OHDA was injected
(Fig. 2A); 2) To identify migrating neuroblasts in the RMS and the
extent of their migration along the RMS, BrdU (50 mg/kg, i.p.)
was administered twice daily for 3 consecutive days beginning 7
days after the 6-OHDA injection, and mice killed 6 days later (i.e.
15 days after 6-OHDA administration) (Fig. 2B); and 3) To label
mature adult-born cells that migrate to, integrate and survive in
the GCL and GL, BrdU (50 mg/kg, i.p.) was administered twice
daily for 5 consecutive days, beginning 8 days after 6-OHDA
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PLoS ONE | www.plosone.org 10 February 2012 | Volume 7 | Issue 2 | e31549injections were performed, and mice killed 30 days later (i.e. 42
days after 6-OHDA administration) (Fig. 2C).
Tissue preparation
All animals were deeply anaesthetized using pentobarbitone
sodium (Lethabarb, Virbac, Milperra, NSW, Australia, 100 mg/
kg i.p.) and perfused through the heart via the ascending aorta
with 20 ml Ca
2+-free Tyrode’s buffer (37uC), followed by 20 ml of
a mixture of 4% paraformaldehyde (Sigma) and 0.2% picric acid
(Sigma) diluted in 0.16 M phosphate buffer (pH 6.9, 37uC) [84,85]
and 50 ml of the same fixative at 4uC, the latter for approximately
5 min. The brains were dissected out and postfixed in the same
fixative for 90 min at 4uC, and finally immersed for 48 h at 4uCi n
10% sucrose dissolved in phosphate buffered saline (PBS, pH 7.4)
containing 0.01% sodium azide (Sigma) and 0.02% bacitracin
(Sigma), before rapid freezing by CO2. Sections were cut using a
cryostat (Leica CM1850, Wetzlar, Germany) at a thickness of
14 microns, and thaw-mounted on slides coated with 0.5%
gelatin- (Sigma) and 0.05% chromium(III) potassium sulphate
dodecahydrate (Merck, KGaA, Darmstadt, Germany).
Immunohistochemistry
Incubation protocol (Diaminobenzidine [DAB]). Sections
were rinsed (3610 min) in 0.01 M PBS, followed by incubation in
blocking diluent [0.01 M PBS containing 5% normal goat serum
(NGS) and 0.3% Triton X-100 (Sigma)] for 30 min, and rabbit
anti-Ki67 antibody (1:15,000, Thermo Fisher Scientific, Fremont,
CA, Code No. RM-9106-s1) diluted in 0.01 M PBS, 1% NGS and
0.3% Triton X-100 for 48 hours at 4uC. Sections were then
incubated in biotinylated goat anti-rabbit (1:1,000, Dako,
Glostrup, Denmark) diluted in 0.01 M PBS, 1% NGS and 0.3%
Triton X-100 for 3 hours at room temperature (RT), and then
avidin peroxidase (1:5000 in 0.01 M PBS and 0.075% Triton X-
100) for 1 hour, followed by and nickel-intensified DAB (1:100,
Sigma) for 20 min. 3% Hydrogen peroxidase (Merck) was added
to the DAB solution for substrate precipitation and the reaction
terminated 2 min later by rinsing sections in 0.01 M PBS. Sections
were counter stained with neutral red, dehydrated in a series of
graded ethanol (50%–100%), cleared in X3B solvent (Shell
Chemicals, Hawthorn East, Australia), and then coverslipped
with DePeX (VWR International, Poole, England). Rinses using
0.01 M PBS (3610 min) were performed between each step.
Incubation protocol (Immunofluorescence). Sections
were washed using 0.01 M PBS (3610 min) and incubated for
24 hours at 4uC with a rat anti-BrdU (1:300, Axyll, Westbury, NY,
Code No. OBT0030), rabbit anti-calbindin (1:10,000, Swant,
Marly, Switzerland, Code No. CB-38a), goat anti-calretinin
(1:4,000, Swant, Code No. CG1), goat anti-doublecortin
(1:1,000, Santa Cruz Biotechnology, Santa Cruz, CA, Code
No. SC-8066), rabbit anti-c-aminobutyric acid (1:2,000, Sigma,
Code No. A2052), rabbit anti-glial fibrillary acidic protein (1:400,
Dako, Code No. Z0334), mouse anti-neuronal nuclei (1:1,000,
Millipore, Billerica, MA, Code No. MAB377), rabbit anti-tyrosine
hydroxylase (1:1,000, Pel-Freeze, Rogers, Ar, Code No. P40101-0)
or sheep anti-tyrosine hydroxylase (1:400, Pel-Freeze, Code
No. P60101-0) antibody, diluted in 0.01 M PBS containing
0.3% Triton X-100 and 0.5% BSA. Sections were then washed
in TNT buffer [0.1 M Tris-HCl, pH 7.5; 0.15 M NaCl; 0.05%
Tween 20 (Sigma)] for 15 min and incubated in TNB buffer
[0.1 M Tris-HCl, pH 7.5; 0.15 M NaCl; 0.5% blocking reagent
(PerkinElmer, Boston, MA, Code No. FP1020)] for 30 min at
room temperature (RT). Immunoreactivity was visualized using
Alexa FluorH 594-conjugated goat anti-rat, Alexa FluorH 488-
conjugated donkey anti-goat, Alexa FluorH 594-conjugated goat
anti-rabbit, Alexa FluorH 488-conjugated goat anti-rabbit, Alexa
FluorH 594-conjugated goat anti-mouse or Alexa FluorH 488-
conjugated donkey anti-sheep (1:200, Molecular Probes, Eugene,
OR), as appropriate, in TNB buffer for 2 hours. Finally, sections
were washed in TNT (3610 min) and coverslipped using a
fluorescent mounting medium (Dako). Hoechst 33342 (1:1000,
Invitrogen, Carlsbad, CA) was applied to sections immunostained
with GFAP for 1.5 min during the third TNT wash, to provide a
nuclear counter stain. Prior to commencing immunoreactivity for
BrdU, antigen retrieval and DNA denaturation was performed,
where sections were incubated in 50% formamide (BDH
Laboratory Supplies, England) in 0.01 M PBS at 65uC for
2 hours, 2 M HCl for 30 min at 37uC, and 0.1 M sodium
borate (BoraxH, Sigma, B-3545) buffer for 10 min at RT.
To visualize calbindin and calretinin immunoreactivity, sections
were processed using a commercial kit (TSA
+, NEN Life Science
Products, Inc., Boston, MA). Briefly, following 24 hour incubation
in primary antisera, sections were washed in TNT buffer (15 min),
incubated with TNB buffer (30 min) and incubated with horse-
radish peroxidase (HRP)-conjugated swine anti-rabbit (1:200,
Dako, Copenhagen, Denmark) or HRP-conjugated donkey anti-
goat (1:500, Jackson ImmunoResearch Laboratories, West Grove,
PA), as appropriate, diluted in TNB buffer for 30 min. Sections
were then washed in TNT buffer (3610 min) and incubated in a
biotinyl tyramide-fluoroscein (BT-FITC) conjugate (NEN) diluted
1:100 in amplification diluent for 10 min at RT, followed by
washes in TNT (3610 min).
Image Processing
After processing, sections were examined using a Leica DMLB2
fluorescence microscope (Leica, Wetzlar, Germany), equipped
with a dark field condenser and epi-polarization, and epifluores-
cence with appropriate filter combinations, and with objective
lenses of 610 (N.A. 0.45), 620 (N.A. 0.70), 640 (N.A. 0.75), 660
oil (N.A. 1.40), and 6100 oil (N.A. 1.30). Photographs were taken
using a Microfire digital camera (2.3A, Optronics, Goleta, CA)
attached to the microscope, operated through Picture Frame
software (v2.3, Optronics). For confocal analysis, an Olympus
FV1000 confocal laser scanning microscope equipped with 610
(N.A. 0.4),620 (N.A. 0.75),640 oil (N.A. 1.30) and660 oil (N.A.
1.35) objectives was used. The Alexa FluorH 488 and FITC
labeling was excited using the 473 nm diode laser. For the
detection of Alexa FluorH 594, a 559 nm diode laser was used. Z-
stack images were captured with multiple images, each separated
by a stepwise depth of 0.4 um in the z-plane. Digital images from
the microscopy were slightly modified to optimize for image
resolution, brightness and contrast using Adobe Photoshop 7.0
software (Adobe Systems Inc., San Jose, CA), so as to best
represent the immunohistochemistry observed at the microscope.
Stereology
For quantification of cell bodies in the SVZ and RMS, the level
at which the anterior commissure (AC) converged through the
midline (Bregma 0.14 mm [82]) was used as a reference to define
the caudal boundary of the SVZ. Serial sections rostral to this
point were acquired, with sections between 0–1400 mm rostral to
the AC convergence (i.e. Bregma 0.14–1.54 mm, [82]) defined as
containing the SVZ, and sections from 1500–4100 mm (i.e.
Bregma 1.6–4.2 mm, [82]) regarded as having the RMS.
Estimates of the number of proliferating cells, neuroblasts and
mature neurons in the SVZ, RMS and OB were made using a
fractionator sampling design according to optical dissector rules
[86,87]. Regular predetermined x, y intervals and counting frame
dimensions for all estimates were derived by means of a grid
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VT, viewed through a microscope, Leica) and are outlined in
Table 2. In all animals, 14 mm-thick sections, each 560 mm apart
(1:40 series), were analyzed, and guard zones of 3 mm (top) and
1 mm (bottom) were employed. For quantification of proliferating
cells and neuroblasts in SVZ, only the lateral wall of the lateral
ventricle was analyzed, as these cells are largely absent in the
medial and dorsal walls [88]. Coefficients of error and coefficients
of variance were used as estimates of precision, with experimental
paradigms accepted only when these coefficients were less than 0.1
[89,90].
Statistical analysis
Data were analyzed using GraphPad Prism 4 (GraphPad
Software, San Diego, CA). All comparisons were conducted by
student t-tests and a value of P,0.05 was considered statistically
significant. Values are expressed as the mean 6 SEM.
Supporting Information
Figure S1 Dopamine denervation in the striatum and
SVZ 42 days following a 6-OHDA-induced lesion of the
SNc. (A) TH-like immunoreactivity (LI) in the intact striatum and
SVZ contralateral to the lesioned SNc. (B) Ablation of TH-LI in
the SVZ ipsilateral to the lesioned SNc, and near complete
denervation in the striatum. LV, lateral ventricle; St, striatum; LS,
lateral septal nucleus; TH, tyrosine hydroxylase. Scale bar in
A=200 mm, applies A and B.
(TIF)
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Table 2. Counting frame dimensions and x, y co-ordinates for estimates of proliferating cells (Ki67, BrdU 2 hours), neuroblasts,
migrating cells (DCX, BrdU 5 days), interneurons and mature cells (NeuN, TH, calbindin, calretinin, GABA, BrdU 30 days) in the SVZ,
RMS and OB.
Antibody Region analyzed Counting frame size (mm) Fractionator x, y coordinates (mm)
Ki67 SVZ/RMS 30620 406100
BrdU (2 hours) SVZ/RMS 40640 506100
BrdU (5 days) SVZ/RMS 30630 506100
BrdU (30 days) OB 50650 1006200
BrdU (30 days) OB 1506150 1506150
DCx SVZ/RMS 30620 706150
NeuN GCL 20620 706300
NeuN GL 30630 706300
TH GL 40640 1006400
Calbindin GL 80680 1006400
Calretinin GL 80680 1006400
Calretinin GCL 80680 1506300
GABA GL 40640 1006400
GABA GCL 20620 1006300
GABA/TH GL 40640 1006400
BrdU (30 days)/TH GL 1506150 1506150
BrdU (30 days)/GABA GCL 50650 1006200
doi:10.1371/journal.pone.0031549.t002
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